Evidence map›Paper›PMID 30972555›Full record

ReviewHuman cell2019

Stem cells in human breast milk.

Natalia Ninkina, Michail S Kukharsky, Maria V Hewitt, Ekaterina A Lysikova, Larissa N Skuratovska, Alexey V Deykin, Vladimir L Buchman

Abstract readReview
In one paragraph

Review in Human cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Breast Milk Stem Cells in the Treatment of Neonatal Diseases.Current stem cell research & therapy · 2025
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Natalia NinkinaInstitute of Physiology Active Compounds, Russian Academy of Sciences, 1 Severnyj Proezd, Chernogolovka, Russian Federation. ninkinan@cf.ac.uk.ORCID http://orcid.org/0000-0001-8570-5648
Michail S KukharskyInstitute of Physiology Active Compounds, Russian Academy of Sciences, 1 Severnyj Proezd, Chernogolovka, Russian Federation.
Maria V HewittInstitute of Physiology Active Compounds, Russian Academy of Sciences, 1 Severnyj Proezd, Chernogolovka, Russian Federation.
Ekaterina A LysikovaInstitute of Physiology Active Compounds, Russian Academy of Sciences, 1 Severnyj Proezd, Chernogolovka, Russian Federation.
Larissa N SkuratovskaThe Institute of General Pathology and Pathophysiology, 8 Baltiyskaya st., Moscow, 125315, Russian Federation.
Alexey V DeykinInstitute of Gene Biology, Russian Academy of Sciences, Vavilova str., 34/5, Moscow, 19334, Russian Federation.
Vladimir L BuchmanInstitute of Physiology Active Compounds, Russian Academy of Sciences, 1 Severnyj Proezd, Chernogolovka, Russian Federation.

Funding

Russian Research Fund 18-15-00357
6 · The paper itself

Abstract

Recent studies have demonstrated that breast milk contains a population of cells displaying many of the properties typical of stem cells. This review outlines progress made in this newly emerging field of stem cell biology and provides an analysis of the available data on purification, propagation and differentiation of certain types of progenitor cells from breast milk. The possible fates of breast milk cells, including microchimerism caused by their transmission to the distant organs of the infant, are also discussed. Unique properties of breast milk-derived stem cells, such as their unusually low tumorigenic potential and their negligible ability to form teratomas, are highlighted as obvious advantages for using these cells in regenerative therapy.

Indexed as

Regenerative MedicineAnimalsCell DifferentiationCell ProliferationHumansMilkStem CellsBreast milkRegenerative medicineSource of human stem cellsStem cells

Identifiers

PMID30972555
PMCPMC6570695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.